Preliminary Evaluation of an Injectable Therapeutic for Cisplatin Ototoxicity Using Neuronal SH-SY5Y Cells
Michelle Hong, Katherine Kedeshian, Larry Hoffman, Ashley Kita, Hiroshi Sakagami, Fumiaki Uchiumi · 2025
Read Preliminary Evaluation of an Injectable Therapeutic for Cisplatin Ototoxicity Using Neuronal SH-SY5Y Cells by Michelle Hong, Katherine Kedeshian, Larry Hoffman, Ashley Kita, Hiroshi Sakagami, Fumiaki Uchiumi (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12735174.txt.
Description
Michelle Hong and co-authors present a 2025 lab study on shielding hearing from a common chemotherapy drug. Cisplatin saves lives but often damages the inner ear's nerve cells. The team used a human nerve-like cell line as a stand-in for those ear neurons to screen protective drugs quickly.
Four candidates were tested alongside the chemotherapy agent. Only one, N-acetylcysteine, kept the cells alive at the winning dose. The winners then loaded the drug into tiny biodegradable particles of varied recipes. Release curves were tracked over two months to find a slow, steady profile. Such particles could one day be injected near the ear for lasting protection. The study is an early step, in dishes rather than patients.
Catalog record
| CREATOR | Michelle Hong, Katherine Kedeshian, Larry Hoffman, Ashley Kita, Hiroshi Sakagami, Fumiaki Uchiumi |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |